Enteris BioPharma
is a biopharmaceutical company that develops peptide-based oral therapeutics for the treatment of metabolic disorders... Read moreEnteris BioPharma
is a biopharmaceutical company that develops peptide-based oral therapeutics for the treatment of metabolic disorders... Read more
News
Oct 26, 2022
PR Newswire
Press Release: Enteris BioPharma : Enteris BioPharma Presents Study of Ovarest Demonstrating Oral Delivery Comparable to or Exceeding Injectable Leuprolide
Sep 12, 2022
MarketScreener
Enteris BioPharma: Enteris BioPharma Publishes White Paper Examining Factors to Consider While Evaluating Oral Administration of Peptides
Aug 03, 2022
MarketScreener
Enteris BioPharma: Enteris BioPharma Manufacturing Expertise Highlighted in Drug Development & Delivery Special Feature on Outsourcing Formulation Development & Manufacturing
Jul 14, 2022
FirstWord Pharma
Enteris BioPharma: Enteris BioPharma Announces Acceptance of Abstract for Oral Presentation at ASRM 2022 Scientific Congress & Expo
Jun 13, 2022
PR Newswire
Press Release: Enteris BioPharma : Enteris BioPharma Presents Data from Two Clinical Studies Involving Oral Formulations of Leuprolide at ENDO 2022 Annual Conference
Jun 07, 2022
MarketScreener
Enteris BioPharma: Enteris BioPharma Publishes White Paper Examining Safe Handling and Manufacture of Highly Potent Active Pharmaceutical Ingredients (HPAPI)
May 04, 2022
PR Newswire
Press Release: Enteris BioPharma : Enteris BioPharma to Exhibit at CPhI North America 2022
Apr 12, 2022
FirstWord Pharma
Enteris BioPharma: Enteris BioPharma Announces Acceptance of Two Abstracts for Presentation at ENDO 2022 Annual Conference
Apr 05, 2022
Indian Pharma Post
Enteris BioPharma: Enteris BioPharma gets featured on its oral drug delivery technology
Mar 07, 2022
centralcharts
Press Release: Enteris BioPharma : Enteris BioPharma Publishes White Paper on Best Practices for Ensuring Content Uniformity in Solid Oral Dosage Manufacturing with HPAPI
Enteris BioPharma Competitors
1
2
3
4
5
6
7
8
9
10